These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 10893763

  • 1. ["Myocardium in hibernation"--implications for clinical medicine].
    Auer J, Berent R, Eber B.
    Wien Med Wochenschr; 2000; 150(6):123-7. PubMed ID: 10893763
    [Abstract] [Full Text] [Related]

  • 2. Coronary artery surgery for ischemic heart failure: risks, benefits, and the importance of assessment of myocardial viability.
    Pitt M, Lewis ME, Bonser RS.
    Prog Cardiovasc Dis; 2001; 43(5):373-86. PubMed ID: 11251125
    [Abstract] [Full Text] [Related]

  • 3. Assessment of myocardial viability.
    Beller GA.
    Curr Opin Cardiol; 1997 Sep; 12(5):459-67. PubMed ID: 9352173
    [Abstract] [Full Text] [Related]

  • 4. Hibernating myocardium: a review.
    Heusch G, Schulz R.
    J Mol Cell Cardiol; 1996 Dec; 28(12):2359-72. PubMed ID: 9004153
    [Abstract] [Full Text] [Related]

  • 5. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A, Popović A.
    Med Pregl; 2000 Dec; 53(3-4):146-53. PubMed ID: 10965679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Myocardial viability in man: state of the art and directions to pursue].
    Vanoverschelde JL.
    Bull Mem Acad R Med Belg; 1999 Dec; 154(1):91-6; discussion 96-8. PubMed ID: 10535159
    [Abstract] [Full Text] [Related]

  • 9. [Assessment of myocardial viability in postinfarction and indications of revascularization].
    Zouaoui W, Ouldzein H, Carrié D.
    Ann Cardiol Angeiol (Paris); 2010 Apr; 59(2):79-85. PubMed ID: 18980750
    [Abstract] [Full Text] [Related]

  • 10. [Viable myocardium: comparative evaluation of surgical and pharmacological treatment of patients with ischemic heart disease, post-infarct cardiosclerosis and chronic cardiac failure].
    Saidova MA, Belenkov IuN, Akchurin RS, Sergienko VB, Khodareva EN, Kostrova VV.
    Ter Arkh; 2002 Apr; 74(2):60-4. PubMed ID: 11899830
    [Abstract] [Full Text] [Related]

  • 11. The multifarious spectrum of ischemic left ventricular dysfunction: relevance of new ischemic syndromes.
    Opie LH.
    J Mol Cell Cardiol; 1996 Dec; 28(12):2403-14. PubMed ID: 9004157
    [Abstract] [Full Text] [Related]

  • 12. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization.
    Penicka M, Tousek P, De Bruyne B, Wijns W, Lang O, Madaric J, Vanderheyden M, Tintera J, Malý M, Widimsky P, Bartunek J.
    Eur Heart J; 2007 Jun; 28(11):1366-73. PubMed ID: 17208936
    [Abstract] [Full Text] [Related]

  • 13. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators.
    Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343
    [Abstract] [Full Text] [Related]

  • 14. Reversible myocardial dysfunction: basics and evaluation.
    Gowda RM, Khan IA, Vasavada BC, Sacchi TJ.
    Int J Cardiol; 2004 Dec 29; 97(3):349-53. PubMed ID: 15561318
    [Abstract] [Full Text] [Related]

  • 15. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH, Yousefnia MA, Roshanali F, Rayatzadeh H, Alaeddini F.
    J Thorac Cardiovasc Surg; 2008 Oct 29; 136(4):930-6. PubMed ID: 18954632
    [Abstract] [Full Text] [Related]

  • 16. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India.
    J Assoc Physicians India; 2006 Jun 29; 54():469-80. PubMed ID: 16909697
    [Abstract] [Full Text] [Related]

  • 17. [Refractory heart failure. Myocardial revascularization as alternative to heart transplantation].
    Alfieri O, Mangia R.
    Ital Heart J Suppl; 2002 Aug 29; 3(8):812-21. PubMed ID: 12407836
    [Abstract] [Full Text] [Related]

  • 18. Relation of improvement in left ventricular ejection fraction versus improvement in heart failure symptoms after coronary revascularization in patients with ischemic cardiomyopathy.
    Rizzello V, Poldermans D, Biagini E, Schinkel AF, Elhendy A, Leone AM, Crea F, Maat A, Roelandt JR, Bax JJ.
    Am J Cardiol; 2005 Aug 01; 96(3):386-9. PubMed ID: 16054464
    [Abstract] [Full Text] [Related]

  • 19. Ischemia, reperfusion, and the role of surgery in the treatment of cardiogenic shock secondary to acute myocardial infarction: an interpretative review.
    Wernly JA.
    J Surg Res; 2004 Mar 01; 117(1):6-21. PubMed ID: 15013709
    [Abstract] [Full Text] [Related]

  • 20. [Revascularization versus transplantation in patients with limited ejection fraction].
    Muñoz Carvajal I, Concha Ruiz M.
    Rev Esp Cardiol; 1998 Mar 01; 51 Suppl 3():106-13. PubMed ID: 9717412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.